Antioxidant plasma concentration and supplementation in carotid intima media thickness

References

• Pearson TA. Cardiovascular disease in developing countries: myths, realities, and opportunities. Cardiovasc. Drug. Ther.13, 94–104 (1999).
   Google Scholar
• Vasan RS, Benjamin EJ, Sullivan LM et al. The burden of increasing worldwide cardiovascular disease. In: Hurst’s, The Heart, 11th Edition. Fuster C, Wayne AR, O’Rourke RA (Eds). McGraw-Hill, NY, USA, 15–36 (2004).
   Google Scholar
• Neaton J, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and difference by age for 316,099 white man. Arch. Intern. Med.152, 56–64 (1992).
   PubMed Web of Science ®Google Scholar
• Rao AV, Rao GL. Carotenoid and human health. Pharmacol. Res.55, 207–216 (2007).
   PubMed Web of Science ®Google Scholar
• Britton G. Structure and properties of carotenoids in relation to function. FASEB. J.9, 1551–1558 (1999).
   Google Scholar
• Riccioni G, Bucciarelli T, Mancini B et al. The role of the antioxidant vitamin supplementation in the prevention of cardiovascular diseases. Expert Opin. Investig. Drugs16, 25–32 (2007).
   PubMed Web of Science ®Google Scholar
• Riccioni G, Bucciarelli T, Mancini B et al. Antioxidant vitamin supplementation in cardiovascular diseases. Ann. Clin. Lab. Sci.37, 89–95 (2007).
   PubMed Web of Science ®Google Scholar
• Thomson MJ, Puntmann V, Kaski JC. Atherosclerosis and oxidant stress: the end of the road for antioxidant vitamin treatment? Cardiovasc. Drugs Ther.21, 195–210 (2007).
   PubMed Web of Science ®Google Scholar
• Tardif JC. Antioxidants: the good, the bad and the ugly. Can. J. Cardiol.22, 61–65 (2006).
   Google Scholar
• Rodrigo R, Guichard C, Charles R. Clinical pharmacology and therapeutic use of antioxidant vitamins. Fundam. Clin. Pharmacol.21, 111–127 (2007).
   PubMed Web of Science ®Google Scholar
• Bleys J, Miller ER 3rd, Pastor-Barriuso R et al. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr.84, 880–887 (2006).
   PubMed Web of Science ®Google Scholar
• Dzau VJ, Antman EM, HR Black et al. The cardiovascular disease continuum validated: clinical evidences of improved patient outcomes. Part I: pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation114, 2850–2870 (2006).
   PubMed Web of Science ®Google Scholar
• Dzau J. Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension37, 1047–1052 (2001).
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. Oxford University Press, NY, USA, 936 (1999).
   Google Scholar
• Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol. Rev.84, 1381–1478 (2004).
   PubMed Web of Science ®Google Scholar
• Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature408, 239–247 (2000).
   PubMed Web of Science ®Google Scholar
• Finkel T. Oxidant signals and oxidative stress. Curr. Opin. Cell. Biol.15, 247–254 (2003).
   PubMed Web of Science ®Google Scholar
• Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br. J. Pharmacol.142, 231–255 (2004).
   PubMed Web of Science ®Google Scholar
• Dizdaroglu M, Jaruga P, Birincioglu M et al. Free radical induced damage to DNA: mechanisms and measurement. Free Radic. Biol. Med.32, 1102–1115 (2002).
   PubMed Web of Science ®Google Scholar
• Halliwell B. Effect of diet on cancer development: is oxidative DNA damage a biomarker? Free Radic. Biol. Med.32, 968–974 (2002).
   PubMed Web of Science ®Google Scholar
• Valko M, Izakovic M, Mazur M et al. Role of oxygen radicals in DNA damage and cancer incidence. Mol. Cell. Biochem.266, 37–56 (2004).
   PubMed Web of Science ®Google Scholar
• Heller FR, Deshamps O, Hondekijn JC. LDL oxidation: therapeutic perspectives. Atherosclerosis137, 25–31 (1998).
   Google Scholar
• Pincemail J. Free radicals and antioxidants in human disease. In: Analysis of Free Radicals in Biological Systems. Favier AE, Cadet J, Kalyanaraman B, Fontecave M, Pierre JL (Eds). Basel, Birkhäuser Verlag, Germany 83–98 (1995).
   Google Scholar
• Ames BN, Gold LS, Willett WC. Causes and prevention of cancer. Proc. Natl Acad. Sci. USA92, 5258–5265 (1995).
   PubMed Web of Science ®Google Scholar
• Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet344, 793–795 (1995).
   Web of Science ®Google Scholar
• Halliwell B. Free radicals, antioxidants and human disease: curiosity, cause or consequence? Lancet334, 721–724 (1994).
   Web of Science ®Google Scholar
• Halliwell B, Murcia MA, Chirico S et al. Free radicals and antioxidants in food and in vivo: what they do and how they work. Crit. Rev. Food Sci. Nutr.35, 7–20 (1995).
   PubMed Web of Science ®Google Scholar
• Sies H, Stahl W. Vitamins E and C, β-carotene, and other carotenoids as antioxidants. Am. J. Clin. Nutr.62, 1315S–1321S (1995).
   PubMed Web of Science ®Google Scholar
• Feri B. Natural Antioxidants in Human Health and Disease. Academic Press San Diego, CA, USA (1994).
   Google Scholar
• World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: a Global Perspective. Washington, DC, USA (1997).
   Google Scholar
• Rimm EB, Stampfer MJ, Ascherio A et al. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med.328, 1450–1456 (1993).
   PubMed Web of Science ®Google Scholar
• Gaziano JM, Manson JE, Branch LG et al. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann. Epidemiol.5, 255–260 (1995).
   PubMedGoogle Scholar
• D’Odorico A, Martines D, Kiechl S et al. High plasma levels of α- and β-carotene are associated with a lower risk of atherosclerosis. Results from the Bruneck study. Atherosclerosis153, 231–239 (2000).
   PubMed Web of Science ®Google Scholar
• Iannuzzi A, Celentano E, Panico S et al. Dietary and circulating antioxidant vitamins in relation to carotid plaques in middle-aged women. Am. J. Clin. Nutr.3, 582–587 (2002).
   Google Scholar
• Dwyer JH, Paul-Labrador MJ, Fan J et al. Progression of carotid intima-media thickness and plasma antioxidants: the Los Angeles Atherosclerosis Study. Arterios. Thromb. Vasc. Biol.24, 313–318 (2004).
   PubMed Web of Science ®Google Scholar
• McQuillan BM, Hung J, Beilby JP et al. Antioxidant vitamins and the risk of carotid atherosclerosis. The Perth Carotid Ultrasound Assessment Study (CUDAS). J. Am. Coll. Cardiol.38, 1788–1794 (2001).
   PubMed Web of Science ®Google Scholar
• Iribarren C, Folsom AR, Jacobs DR Jr et al. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case–control study. The ARIC Study Investigators. Atherosclerosis Risk in Communities. Arterioscler. Thromb. Vasc. Biol.7, 1171–1177 (1997).
   Google Scholar
• Polidori MC, Praticò D, Parente B et al. Elevated lipid peroxidation biomarkers and low antioxidant status in atherosclerosis patients with increased carotid or iliofemoral intima media thickness. J. Invest. Med.55, 163–167 (2007).
   PubMed Web of Science ®Google Scholar
• Giannetti J, Perinelli R, Petrucci R et al. Inverse association between carotid intima-media thickness and the antioxidant lycopene in atherosclerosis. Am. Heart. J.143, 467–474 (2002).
   PubMed Web of Science ®Google Scholar
• Bolton-Smith C, Woodward M, Tunstall-Pedoe H. The Scottish Heart Health Study. Dietary intake by food frequency questionnaire and odds ratios for coronary heart disease risk, II: the antioxidant vitamins and fibre. Eur. J. Clin. Nutr.46, 85–93 (1992).
   PubMed Web of Science ®Google Scholar
• Rimm EB, Stampfer MJ, Ascherio A et al. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med.328, 1450–1456 (1993).
   PubMed Web of Science ®Google Scholar
• Rissanen TH, Voutilainen S, Nyyssonen K et al. Serum lycopene concentration and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am. J. Clin. Nutr.77, 13–18 (2003).
   Google Scholar
• Salonen JT, Nyyssönen K, Salonen R et al. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J. Intern. Med.248, 377–386 (2000).
   PubMed Web of Science ®Google Scholar
• Salonen RM, Nyyssönen K, Kaikkonen J et al. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation107, 947–953 (2003).
   PubMed Web of Science ®Google Scholar
• Nanayakkara PW, van Guldener C, ter Wee PM et al. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study. Arch. Intern. Med.167, 1262–1270 (2007).
   PubMedGoogle Scholar
• Magliano D, McNeil J, Branley P et al. The Melbourne Atherosclerosis Vitamin E Trial (MAVET): a study of high dose vitamin E in smokers. Eur. J. Cardiovasc. Prev. Rehabil.13, 341–347 (2006).
   PubMed Web of Science ®Google Scholar
• Zureik M, Galan P, Bertrais S et al. Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries. Arterioscler. Thromb. Vasc. Biol.24, 1485–1491 (2004).
   PubMed Web of Science ®Google Scholar
• Hodis HN, Mack WJ, LaBree L et al. α-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation106, 1453–1459 (2002).
   PubMed Web of Science ®Google Scholar